Skip to content

BMY vs LLY: Dividend Comparison

BMY$60.77
Bristol Myers Squibb Co
Health Care
vs
LLY$1,406.28
ELI LILLY & Co
Health Care

Dividend data as of

Bristol Myers Squibb Co (BMY) and ELI LILLY & Co (LLY) are both in the Health Care sector, making them natural rivals for dividend investors. BMY offers a significantly higher 4.00% yield compared to LLY's 0.48%, a gap of 3.52%. For dividend growth, LLY leads with a 5-year CAGR of 15.3% versus BMY's 5.1%. Both stocks carry a "Safe" dividend safety rating. Both are classified as Dividend Contenders.

Verdict

Best for Income
BMY
Higher yield at 4.00%
Best for Growth
LLY
5yr CAGR of 15.3%
Best for Safety
LLY
Lower payout ratio (22%)

Track BMY and LLY in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan (1 portfolio, 10 holdings).

30-day free brokerage sync trial. No credit card. Then from $9.99/month. Choosing a tracker? See the best dividend trackers compared.

Metric
Price
$60.77
$1,406.28
Dividend Yield
4.00%
0.48%
Annual Dividend
$2.52
$6.92
5yr Div CAGR
5.1%
15.3%
3yr Div CAGR
3.4%
15.3%
Consecutive Years
18
11
Payout Ratio
55.88%
21.71%
P/E Ratio
—
—
Market Cap
—
—
Income on $10k
$400/yr
$48/yr

Yield Analysis

BMY
4.00%
LLY
0.48%

BMY yields 3.52% more than LLY. In dollar terms, BMY pays $2.52/share vs LLY's $6.92/share annually.

Dividend Growth

BMY 5yr CAGR
5.1%
decelerating
LLY 5yr CAGR
15.3%
steady

BMY: Dividend growth is slowing — the 3-year CAGR of 3.4% trails the 5-year rate of 5.1% and the 10-year rate of 5.2%.

LLY: Dividend growth has been steady, with a 3-year CAGR of 15.3% and a 5-year CAGR of 15.3% (10-year: 13.0%).

Dividend Safety

BMY
Safe
Payout Ratio56%
LLY
Safe
Payout Ratio22%

BMY: The payout ratio of 56% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 1.8x.

LLY: The payout ratio of 22% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 4.5x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
BMY
LLY
$10,000
$400/yr
$48/yr
$50,000
$2,002/yr
$241/yr
$100,000
$4,004/yr
$482/yr

What does $10,000 buy in BMY vs LLY today?

At $60.77 per share, $10,000 buys about 164.6 shares of Bristol Myers Squibb Co (BMY). Each share pays $2.52 per year in dividends, so the position starts out generating roughly $415 per year — about $35 a month.

At $1406.28 per share, $10,000 buys about 7.1 shares of ELI LILLY & Co (LLY). Each share pays $6.92 per year in dividends, so the position starts out generating roughly $49 per year — about $4 a month.

BMY is the larger income stream from day one: $366 per year more on the same $10,000 invested.

What could $10,000 of BMY or LLY income look like in 10 years?

Bristol Myers Squibb Co (BMY) has raised its dividend about 5.1% a year over the past five years. If that pace held, the $400 per year that $10,000 generates today at the current 4.00% yield would reach $662 per year by 2036 — a 6.6% yield on the original cost.

ELI LILLY & Co (LLY) has raised its dividend about 15.3% a year over the past five years. If that pace held, the $48 per year that $10,000 generates today at the current 0.48% yield would reach $200 per year by 2036 — a 2.0% yield on the original cost.

On those trailing rates, BMY pays more in 2036: $662 versus $200 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would LLY's dividend growth overtake BMY's higher yield?

ELI LILLY & Co (LLY) yields less today (0.48% vs 4.00%) but has grown its dividend faster — 15.3% vs 5.1% a year over the past five years. If both trends continued, a $10,000 position in LLY would start out-earning the same position in BMY around 2050 (roughly 24 years from now), paying about $1,459 per year at the crossover. Before that point, BMY pays more each year; after it, the gap compounds in LLY's favor.

Can BMY and LLY afford their dividends?

Bristol Myers Squibb Co (BMY) earns $4.51 per share against $2.52 paid out in dividends — 1.8x coverage (a 56% payout ratio).

ELI LILLY & Co (LLY) earns $30.81 per share against $6.92 paid out in dividends — 4.5x coverage (a 22% payout ratio).

LLY's wider coverage leaves more cushion if earnings dip. As a rule of thumb, coverage below about 1.5x (a payout ratio above ~65%) is where a dividend starts to look stretched — worth watching for BMY if earnings weaken.

Which fits an early-retirement income portfolio better, BMY or LLY?

For income you need right now, Bristol Myers Squibb Co (BMY) leads: $100,000 invested today pays about $334 a month at the current 4.00% yield, versus $40 a month from ELI LILLY & Co (LLY) at 0.48%.

With a decade or more before the income is needed, LLY's faster dividend growth (15.3% vs 5.1% a year) matters more than the starting yield — raises compound into the larger paycheck over time.

On consistency: BMY has raised its dividend 18 consecutive years; LLY has raised its dividend 11 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $980/yr in BMY vs $209/yr in LLY by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.